157 related articles for article (PubMed ID: 18646510)
1. N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions.
Kim SJ; Shin ES; Lee SG
Korean J Intern Med; 2008 Jun; 23(2):78-86. PubMed ID: 18646510
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal pro-brain natriuretic peptide concentrations before and after pericardiocentesis in dogs with cardiac tamponade secondary to spontaneous pericardial effusion.
Baumwart RD; Hanzlicek AS; Lyon SD; Lee PM
J Vet Cardiol; 2017 Oct; 19(5):416-420. PubMed ID: 28988688
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal pro-B-type natriuretic peptide as a predictor of disease progression in patients with pericardial effusion.
Hwang DS; Kim SJ; Shin ES; Lee SG
Int J Cardiol; 2012 May; 157(2):192-6. PubMed ID: 21194766
[TBL] [Abstract][Full Text] [Related]
4. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
[TBL] [Abstract][Full Text] [Related]
6. Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies.
Mady C; Fernandes F; Arteaga E; Ramires FJ; Buck Pde C; Salemi VM; Ianni BM; Nastari L; Dias RR
Arq Bras Cardiol; 2008 Jul; 91(1):46-54. PubMed ID: 18660945
[TBL] [Abstract][Full Text] [Related]
7. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
[TBL] [Abstract][Full Text] [Related]
9. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
10. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
[TBL] [Abstract][Full Text] [Related]
11. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
Amjad S; Sami SA; Basir MN; Hameed K; Fujita M; Ahmad HR
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):160-5. PubMed ID: 24532613
[TBL] [Abstract][Full Text] [Related]
12. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
13. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.
Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS
Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
[TBL] [Abstract][Full Text] [Related]
17. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
19. Uric acid level is positively associated with NT-proBNP concentration in Slovak heart failure patients.
Sabaka P; Dukat A; Gajdosik J; Caprnda M; Bendzala M; Simko F
Physiol Res; 2019 Oct; 68(5):767-774. PubMed ID: 31441313
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
